[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:chronic-obstructive-pulmonary-disease:eosinophil-count":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Chronic Obstructive Pulmonary Disease","Eosinophil Count",3,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06283966","A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease",[12],"Phase 3","RECRUITING","2026-08-26T02:17:09.131534Z","2026-05-05T02:43:29.527616Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07190209","Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype",[12],"2026-08-26T02:17:54.420226Z","2026-05-05T02:35:31.713460Z",{"nct_id":23,"title":24,"phases":25,"status":27,"updated_at":28,"content_modified":29},"NCT06940154","Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)",[26],"Phase 2","ACTIVE_NOT_RECRUITING","2026-08-03T03:06:01.435370Z","2026-06-16T05:54:07.928811Z"]